☆ 4.3 Editorial Material

VALUING HEALTH TECHNOLOGIES AT NICE: RECOMMENDATIONS FOR IMPROVED INCORPORATION OF TREATMENT VALUE IN HTA

HEALTH ECONOMICS (2010)

Journal

HEALTH ECONOMICS

Volume 19, Issue 10, Pages 1109-1116

Publisher

WILEY

DOI: 10.1002/hec.1654

Keywords

-

Categories

Economics Health Care Sciences & Services Health Policy & Services

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Editorial Material Health Care Sciences & Services

Capturing what matters: updating NICE methods guidance on measuring and valuing health

Dalia Dawoud, Alan Lamb, Alan Moore, Caroline Bregman, Ewa Rupniewska, Thomas Paling, Verena Wolfram, Rosemary E. S. Lovett, Ross Dent

Summary: This paper reports a major review conducted by the National Institute for Health and Care Excellence (NICE) on its health technology evaluation methods, with a focus on the measurement and valuation of health-related quality of life. The review proposes changes to NICE methods and highlights areas where further research is needed.

QUALITY OF LIFE RESEARCH (2022)

Add to Collection

Review Pharmacology & Pharmacy

Recommendations for the Implementation of Hospital Based HTA in Poland: Lessons Learned From International Experience

Malgorzata Galazka-Sobotka, Iwona Kowalska-Bobko, Krzysztof Lach, Aneta Mela, Maciej Furman, Iga Lipska

Summary: This study analyzed HB-HTA systems/models in selected European countries to provide an optimal approach for implementing HB-HTA in Poland. The research highlighted the differences in organizational models, financing types, and stakeholder collaborations in HB-HTA among the countries studied.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges

Rita Daubner-Bendes, Sandor Kovacs, Maciej Niewada, Mirjana Huic, Michael Drummond, Oriana Ciani, Carl Rudolf Blankart, Olena Mandrik, Aleksandra Torbica, John Yfantopoulos, Guenka Petrova, Malwina Holownia-Voloskova, Rod S. Taylor, Maiwenn Al, Oresta Piniazhko, Laszlo Lorenzovici, Rosanna Tarricone, Antal Zemplenyi, Zoltan Kalo

Summary: The study provides guidance for Central and Eastern European countries on addressing key challenges of health technology assessment for medical devices, with a focus on the transferability of scientific evidence.

FRONTIERS IN PUBLIC HEALTH (2021)

Add to Collection

Review Pediatrics

The Challenges of Measuring and Valuing Quality of Life in Preschool Children: A Retrospective Review of NICE Appraisals

Alan Lamb, Alice Murray, Rosie Lovett

Summary: The study reviewed the methods used to capture the HRQoL of preschool children in past NICE appraisals, finding that most appraisals used generic HRQoL measures designed for adults, highlighting challenges in data collection, valuation studies, and mapping. Research priorities include improving existing measures, assessing feasibility and validity of valuation studies, and mapping, in order to better capture aspects of HRQoL that matter to children and their families in NICE evaluations.

CHILDREN-BASEL (2021)

Add to Collection

Article Health Care Sciences & Services

The NICE Evidence Standards Framework for digital health and care technologies - Developing and maintaining an innovative evidence framework with global impact

Harriet Unsworth, Bernice Dillon, Lucie Collinson, Helen Powell, Mark Salmon, Tosin Oladapo, Lynda Ayiku, Gary Shield, Joanne Holden, Neelam Patel, Mark Campbell, Felix Greaves, Indra Joshi, John Powell, Alexia Tonnel

Summary: The ESF is a standardized framework developed in 2018 by NICE in partnership with various UK health organizations to guide developers and commissioners on the evidence levels required for evaluating DHTs. The framework has been well-received and has had a significant impact globally, with ongoing efforts to maintain and improve it in a rapidly evolving field.

DIGITAL HEALTH (2021)

Add to Collection

Review Public, Environmental & Occupational Health

International practices in health technology assessment and public financing of digital health technologies: recommendations for Hungary

Fruzsina Mezei, Krisztian Horvath, Mate Palfi, Kornelia Lovas, Ildiko Adam, Gergo Turi

Summary: This paper provides an overview of international practices on public financing and health technology assessment of digital health technologies (DHTs) in five European Union (EU) countries, and offers recommendations for supporting the uptake of digital health solutions in Hungary. The study found that there is no unified framework or method for classifying, evaluating, and financing DHTs in the European context. The authors suggest that stakeholders should play an active role in developing common clinical evidence standards and technical quality criteria.

FRONTIERS IN PUBLIC HEALTH (2023)

Add to Collection

Article Economics

Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?

Tracy Merlin, Jackie Street, Drew Carter, Hossein Haji Ali Afzali

Summary: There is deep uncertainty about the clinical benefits and cost effectiveness of highly specialised technologies (HSTs). Standard health technology assessment processes have failed to address these uncertainties. A Living HTA framework is proposed to address these challenges by incorporating societal values, real-time data collection, and updating of reference models.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2023)

Add to Collection

Editorial Material Medicine, General & Internal

Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast]

Michael F. Drummon, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers

Summary: This episode focuses on the importance of payers and Health Technology Assessment (HTA). Professor Drummond explains why demonstrating the value of new interventions has become crucial.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

Add to Collection

Article Ethics

Does NICE apply the rule of rescue in its approach to highly specialised technologies?

Victoria Charlton

Summary: This paper explores NICE's approach to evaluating ultra-orphan drugs and whether it applies the 'rule of rescue', concluding that although NICE claims not to prioritize these drugs based on the rule, its actions align with it and are not supported by any alternative rationale. The paper suggests that NICE's rejection of the rule is unhelpful and raises questions about its transparency and fairness as a decision-maker.

JOURNAL OF MEDICAL ETHICS (2022)

Add to Collection

Article Business, Finance

Valuing options to renew at future market value: the case of commercial property leases

Jenny Jing Wang, Jianfu Shen, Frederik Pretorius

Summary: In this study, a valuation model for a commonly encountered option in office leases is developed and empirically tested. The model integrates decision analysis with real options analysis and market risk with private risks. The study provides a theoretical analysis and empirical tests of the value of a real option that allows option holders to renew/extend their contracts at a fair market value.

FINANCIAL INNOVATION (2023)

Add to Collection

Article Medicine, General & Internal

Cost-consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK

Antony Wright, Helene Vioix, Shamika de Silva, Sue Langham, Jennifer Cook, Toby Capstick, Jennifer K. Quint

Summary: This study models the clinical and economic impact of adapting current clinical practice in the management of patients with chronic obstructive pulmonary disease (COPD) to treatment according to national and international guideline recommendations. Treating patients according to guidelines can lead to substantial cost savings.

BMJ OPEN (2022)

Add to Collection

Article Health Care Sciences & Services

Recommendations for Designing Health Information Technologies for Mental Health Drawn From Self-Determination Theory and Co-design With Culturally Diverse Populations: Template Analysis

Vanessa Wan Sze Cheng, Sarah E. Piper, Antonia Ottavio, Tracey A. Davenport, Ian B. Hickie

Summary: The study identified that the expressed needs of culturally diverse Australians for mental health HIT broadly align with universal design principles. The findings support the application of self-determination theory in HIT design and highlight the challenges in designing technologies for complex problems overlapping multiple domains. Additionally, the study provides general recommendations for designing mental health HITs based on identified themes from participant recommendations.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Add to Collection

Article Health Care Sciences & Services

Uncertainty tolerance among experts involved in drug reimbursement recommendations: Qualitative evidence from HTA committees in Canada and Poland

Wieslawa Dominika Wranik, Liesl Gambold, Stuart Peacock

Summary: The study found that there is variation in uncertainty tolerance among committee members and other stakeholders, depending on their backgrounds and decision contexts. Some rationalize that uncertainty increases potential harm, while others believe that patients often have no alternatives.

HEALTH POLICY (2021)

Add to Collection

Article Health Care Sciences & Services

Implementation of a new Digi-HTA process for digital health technologies in Finland

Jari Haverinen, Miia Turpeinen, Petra Falkenbach, Jarmo Reponen

Summary: This study explores the use of the Digi-HTA method for evaluating novel digital health technologies in Finland. Feedback from healthcare professionals and input from DHT companies suggests that the Digi-HTA framework is suitable for assessing different types of DHT products, although there is room for improvement in integrating the recommendations into healthcare decision-making processes.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2022)

Add to Collection

Review Health Care Sciences & Services

A review of HTA guidelines on societal and novel value elements

Rachel Milstein Breslau, Joshua T. Cohen, Jose Diaz, Bill Malcolm, Peter J. Neumann

Summary: Health technology assessment organizations vary in their adoption of societal and novel elements in their evaluations. A study reviewed 53 guidelines and found that most do not recommend including these elements in assessments.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2023)

Add to Collection

Article Economics

Predicting quantity and quality of life with the Future Elderly Model

Duncan Ermini Leaf, Bryan Tysinger, Dana P. Goldman, Darius N. Lakdawalla

Summary: The validation analysis of the Future Elderly Model (FEM) shows that its mortality and longevity forecasts are generally consistent with observed data, while also providing policy simulation features that are not available in traditional actuarial models.

HEALTH ECONOMICS (2021)

Add to Collection

Article Economics

Improved survival for individuals with common chronic conditions in the Medicare population

Benjamin G. Cohen, Dana P. Goldman, Jessica Y. Ho, Daniel L. McFadden, Martha S. Ryan, Bryan Tysinger

Summary: While the United States ranks poorly in life expectancy compared to other developed countries, there are differences in survival trends among different age groups, with those over 65 showing better outcomes. Progress in treating chronic conditions has led to improvements in survival rates and the narrowing of racial disparities over time.

HEALTH ECONOMICS (2021)

Add to Collection

Article Health Care Sciences & Services

Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer

Meng Li, Dana P. Goldman, Alice J. Chen

Summary: For patients with advanced-stage breast cancer, increased spending on targeted therapies is associated with decreased cancer mortality rates, while there is no such association for patients with early-stage cancer. Other types of spending, such as on nontargeted therapies and other cancer care, do not affect mortality rates for either early- or advanced-stage cancer patients.

HEALTH AFFAIRS (2021)

Add to Collection

Article Economics

The future of the elderly population health status: Filling a knowledge gap

Vincenzo Atella, Federico Belotti, Daejung Kim, Dana Goldman, Tadeja Gracner, Andrea Piano Mortari, Bryan Tysinger

Summary: This study uses dynamic microsimulation models to project health outcomes in 12 OECD countries, finding that chronic disease prevalence in Europe is catching up to that in the United States and significant heterogeneity exists in the evolution of gender and education gradients. These findings provide important insights for policymakers in designing and implementing effective interventions in the healthcare sector.

HEALTH ECONOMICS (2021)

Add to Collection

Article Medicine, General & Internal

Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018

Darius Lakdawalla, Meng Li

Summary: This study revealed a significant increase in out-of-pocket burden for patients paying coinsurance on drug list prices between 2014 and 2018, especially in markets with more pharmaceutical competition. Passing rebates through to patients at the point of sale could potentially restore the benefits of competition and rebates.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Medicine, General & Internal

Measuring the COVID-19 Mortality Burden in the United States A Microsimulation Study

Julian Reif, Hanke Heun-Johnson, Bryan Tysinger, Darius Lakdawalla

Summary: This study measured the years of life lost and quality-adjusted life-years lost due to the COVID-19 pandemic, finding that individuals aged 25 to 64 were most heavily affected, with a disproportionate burden on Black and Hispanic communities.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Correction Economics

Health technology assessment with risk aversion in health (vol 72, 102346, 2020)

Darius N. Lakdawalla, Charles E. Phelps

JOURNAL OF HEALTH ECONOMICS (2021)

Add to Collection

Article Social Sciences, Interdisciplinary

Effect of COVID-19 vaccine allocation strategies on vaccination refusal: a national survey

Wandi Bruine de Bruin, Aulona Ulqinaku, Dana P. Goldman

Summary: The study shows that once people are overlooked in vaccine allocation, they may no longer want to get vaccinated. Most participants preferred prioritizing vaccines for high-risk individuals, but a significant number indicated they would refuse vaccination if passed over.

JOURNAL OF RISK RESEARCH (2022)

Add to Collection

Article Economics

A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE)

Darius N. Lakdawalla, Charles E. Phelps

Summary: The GRACE model introduces diminishing returns to QoL, reshaping conventional CEA practice in terms of WTP, treatment effectiveness adjustment, and the substitution rate between life expectancy and QoL based on health state. Implementing GRACE requires new parameters to describe risk preferences, the marginal rate of substitution, and treatment outcomes distributions.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2022)

Add to Collection

Article Clinical Neurology

The costs of developing treatments for Alzheimer's disease: A retrospective exploration

Jeffrey L. Cummings, Dana P. Goldman, Nicholas R. Simmons-Stern, Eric Ponton

Summary: Over the past 26 years, the private sector has invested a total of $42.5 billion in the development of Alzheimer's disease drugs, with the majority of costs incurred during phase 3 clinical trials. This calls for continued investment from industry, government, and academia to reduce expenses and develop disease-modifying therapies for Alzheimer's disease.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Article Clinical Neurology

Crosswalk between the Mini-Mental State Examination and the Telephone Interview for Cognitive Status (TICS-27/30/40)

Jakub P. Hlavka, Jeffrey C. Yu, Darius N. Lakdawalla

Summary: This study presents a crosswalk between MMSE and TICS, providing a comparable cognitive measurement tool for adults aged 65 and older.

ALZHEIMERS & DEMENTIA (2022)

Add to Collection

Editorial Material Oncology

Considerations in the implementation of multicancer early detection tests

Lincoln Nadauld, Dana P. Goldman

FUTURE ONCOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Association between use of ss2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis

Hasan Nadeem, Bo Zhou, Dana Goldman, John Romley

Summary: The use of β2-agonists in patients with chronic lung disease is associated with a decreased risk of developing Parkinson's disease, suggesting a potential protective effect.

PLOS ONE (2022)

Add to Collection

Article Clinical Neurology

Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials

Jeffrey C. Yu, Jakub P. Hlavka, Elizabeth Joe, Frances J. Richmond, Darius N. Lakdawalla

Summary: This study examines the impact of two FDA guidance documents for Alzheimer's disease (AD) trials and finds that these documents are broadly followed by trialists.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)

Add to Collection

Meeting Abstract Economics

DEVELOPMENT OF A SURVEY-BASED PREDICTIVE MODEL FOR CLINICAL DEMENTIA RATING IN ALZHEIMER'S DISEASE

J. C. Yu, J. Hlavka, B. Tysinger, D. Lakdawalla

VALUE IN HEALTH (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.